Document Detail


Contrasting effects of n-3 and n-6 fatty acids on cyclooxygenase-2 in model systems for arthritis.
MedLine Citation:
PMID:  19784684     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cyclooxygenase-2 (COX-2) is intimately involved in symptoms of arthritis while dietary n-3 polyunsaturated fatty acids (PUFA) are thought to be beneficial. In these experiments, using both bovine and human in vitro systems that mimic features of arthritis, we show that the n-3 PUFA eicosapentaenoic acid (EPA) is able to reduce mRNA and protein levels of COX-2. Activity, as assessed through prostaglandin E(2) formation, was also reduced in a dose-dependent manner. These effects of EPA contrasted noticeably with the n-6 PUFA, arachidonic acid. The data provide direct evidence for a molecular mechanism by which dietary n-3 PUFA, such as EPA, can reduce inflammation and, hence, associated symptoms in arthritis.
Authors:
Samantha Hurst; Sarah G Rees; Peter F Randerson; Bruce Caterson; John L Harwood
Related Documents :
19329744 - Mimicking the natural doping of migrant sandpipers in sedentary quails: effects of diet...
11890054 - Canned cod liver as a source of n-3 polyunsaturated fatty acids, with a reference to co...
12624484 - Metabolism of long-chain polyunsaturated fatty acids in rat kidney cells.
17127474 - Relationships between flavour, lipid composition and antioxidants in organic, free-rang...
21552764 - Treatment of a textile effluent from dyeing with cochineal extracts using trametes vers...
17239514 - Linuron and carbaryl differentially impair baseline amino acid and bile salt olfactory ...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-09-26
Journal Detail:
Title:  Lipids     Volume:  44     ISSN:  1558-9307     ISO Abbreviation:  Lipids     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2010-01-29     Completed Date:  2010-08-27     Revised Date:  2011-12-01    
Medline Journal Info:
Nlm Unique ID:  0060450     Medline TA:  Lipids     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  889-96     Citation Subset:  IM    
Affiliation:
Cardiff School of Biosciences, Cardiff University, Museum Avenue, Cardiff, CF10 3AX, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Arthritis / diet therapy*,  enzymology*,  pathology
Cartilage, Articular / drug effects,  enzymology,  pathology
Cattle
Cells, Cultured
Cyclooxygenase 2 / biosynthesis,  metabolism*
Cyclooxygenase 2 Inhibitors / pharmacology,  therapeutic use
Dietary Fats / pharmacology,  therapeutic use
Fatty Acids, Omega-3 / pharmacology*,  therapeutic use
Fatty Acids, Omega-6 / pharmacology*,  therapeutic use
Humans
Grant Support
ID/Acronym/Agency:
D16961//Biotechnology and Biological Sciences Research Council; //Arthritis Research UK
Chemical
Reg. No./Substance:
0/Cyclooxygenase 2 Inhibitors; 0/Dietary Fats; 0/Fatty Acids, Omega-3; 0/Fatty Acids, Omega-6; EC 1.14.99.1/Cyclooxygenase 2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-chain Ceramide Produced in Response to N-Hexanoylsphingosine does not Induce Apoptosis in CHP-1...
Next Document:  The results of downgrading moderate and severe slipped capital femoral epiphysis by an early Imhause...